These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11809774)

  • 21. LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling.
    Li L; Naples M; Song H; Yuan R; Ye F; Shafi S; Adeli K; Ng DS
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E587-94. PubMed ID: 17551001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
    Gong EL; Nichols AV; Weisgraber KH; Forte TM; Shore VG; Blanche PJ
    Biochim Biophys Acta; 1989 Dec; 1006(3):317-28. PubMed ID: 2597674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
    Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
    J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice.
    Stukas S; Freeman L; Lee M; Wilkinson A; Ossoli A; Vaisman B; Demosky S; Chan J; Hirsch-Reinshagen V; Remaley AT; Wellington CL
    J Lipid Res; 2014 Aug; 55(8):1721-9. PubMed ID: 24950691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.
    Willner EL; Tow B; Buhman KK; Wilson M; Sanan DA; Rudel LL; Farese RV
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1262-7. PubMed ID: 12538880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
    Calabresi L; Baldassarre D; Castelnuovo S; Conca P; Bocchi L; Candini C; Frigerio B; Amato M; Sirtori CR; Alessandrini P; Arca M; Boscutti G; Cattin L; Gesualdo L; Sampietro T; Vaudo G; Veglia F; Calandra S; Franceschini G
    Circulation; 2009 Aug; 120(7):628-35. PubMed ID: 19687369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
    Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
    Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
    J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
    Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
    APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144.
    Teh EM; Chisholm JW; Dolphin PJ; Pouliquen Y; Savoldelli M; de Gennes JL; Benlian P
    Atherosclerosis; 1999 Sep; 146(1):141-51. PubMed ID: 10487497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial lecithin-cholesterol acyltransferase: identification of heterozygotes with half-normal enzyme activity and mass.
    Albers JJ; Chen C; Adolphson JL
    Hum Genet; 1981; 58(3):306-9. PubMed ID: 7327552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice.
    Lee JY; Badeau RM; Mulya A; Boudyguina E; Gebre AK; Smith TL; Parks JS
    J Lipid Res; 2007 May; 48(5):1052-61. PubMed ID: 17272829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triacetyl-3-hydroxyphenyladenosine, a derivative of cordycepin, attenuates atherosclerosis in apolipoprotein E-knockout mice.
    Zhao Z; Song G; Tian H; Yu Y; Tian X; Liu J; Yao S; Luo T; Qin S
    Exp Biol Med (Maywood); 2012 Nov; 237(11):1262-72. PubMed ID: 23239437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.